Supplemental material
Open access
1,414
Views
2
CrossRef citations to date
0
Altmetric
Original Articles
Characteristics of pregnant women with diabetes using injectable glucose-lowering drugs in the EVOLVE study
Elisabeth R. Mathiesena Center for Pregnant Women with Diabetes, Rigshospitalet, University of Copenhagen, Copenhagen, DenmarkCorrespondence[email protected]
https://orcid.org/0000-0003-3279-0863View further author information
, https://orcid.org/0000-0003-3279-0863View further author information
Norsiah Alib Masjid Tanah Health Clinic, Malacca, MalaysiaView further author information
, Eleni Anastasiouc Department of Endocrinology-Diabetes Center, Alexandra Hospital, Athens, GreeceView further author information
, Katarzyna Cyprykd Department of Internal Medicine and Diabetology, Medical University of Łódź, Łódź, PolandView further author information
, Harold W. de Valke Department of Internal Medicine, University Medical Centre Utrecht, Utrecht, The NetherlandsView further author information
, Jorge M. Doresf Department of Endocrinology, Centro Hospitalar e Universitário do Porto, Porto, PortugalView further author information
, Fidelma P. Dunneg Department of Medicine, Galway Diabetes Research Centre, National University of Ireland Galway, Galway, IrelandView further author information
, Magnus Ekelundh Novo Nordisk A/S, Søborg, DenmarkView further author information
, Santiago Durán Garcíai Endodiabesidad: Clínica Durán & Asociados, Seville, SpainView further author information
, Hélène Hanairej Department of Diabetology, Metabolic Diseases and Nutrition, University Hospital of Toulouse, University of Toulouse, Toulouse, FranceView further author information
, Lise Lotte N. Husemoenh Novo Nordisk A/S, Søborg, DenmarkView further author information
, Marina Ivanisevick Department of Obstetrics and Gynecology, Clinical Hospital Center Zagreb, Zagreb, CroatiaView further author information
, Hans-Peter Kempel Centre for Diabetes and Nutrition Ludwigshafen, Ludwigshafen, GermanyView further author information
, Rikke B. Nordsborgh Novo Nordisk A/S, Søborg, DenmarkView further author information
& David R. McCancem Metabolic Unit, Royal Victoria Hospital, Belfast, UKView further author information
show all
Pages 7992-8000
|
Received 24 Mar 2021, Accepted 04 Jun 2021, Published online: 28 Jun 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.